Preventing Organ Failure Through Early Detection

Delayed Treatment Costs Lives

Opticyte is transforming the standard of care for the leading causes of organ failure, including sepsis, with real-time measurement.

The opportunity to save lives and improve patient care is global in scale with immense societal impact. There are 48.9 million sepsis cases and 11 million sepsis-related deaths as a result of organ failure worldwide each year. One person in the world dies every three seconds from organ failure related to sepsis, accounting for 20% of all deaths globally. Others survive only to endure prolonged periods of critical illness and dependency on vital organ support. The financial burden of treating sepsis costs the U.S. healthcare system alone nearly $25 billion dollars annually.*

Million sepsis cases worldwide each year
Million sepsis-related deaths worldwide each year

The Need is Now for Definitive, Actionable Oximetry Data

Every minute counts when a patient’s organs aren’t receiving enough oxygen. Today’s technology, including pulse oximeters, fails to provide clinicians with definitive, real-time information that can be used to prevent organ failure. Current methods for diagnosis rely on indirect indicators of cellular oxygen levels that are often too delayed, ambiguous or inaccurate to help clinicians determine the correct dose and timing of treatment.

With Opticyte’s Cell O₂ Monitor, clinicians can immediately respond to a patient’s urgent medical condition with confidence to prevent irreversible organ damage and failure.

Recognized by the FDA as a Breakthrough Device, the Opticyte Cell O₂ Monitor is the first device to measure oxygen levels inside cells in real time.

Organ failure results from prolonged, untreated low oxygen levels in cells due to sepsis, COVID-19, hemorrhage (blood loss), or cardiac failure. The US FDA awarded Opticyte’s Cell O₂ Monitor Breakthrough Device Designation for its potential to provide more effective treatment over the existing standard of care for identifying and treating life-threatening organ dysfunction.

“The Opticyte Cell O₂ Monitor has the potential for detecting mild to moderate shock during the ‘Golden Hour’ when the clinician still has the opportunity to reverse potentially fatal deterioration with current therapies.”

Robert Guthrie, MD, Drexel University

The World’s Only
Cell O₂ Monitor

Opticyte Render

The Opticyte Cell O₂ Monitor leverages proprietary advanced algorithms, tailored optical spectroscopy technology, and a functional, form-fitting disposable sensor to continuously measure oxygen levels inside cells in real time. The world’s first cellular oxygen monitor provides clinicians immediate, actionable insights related to organ oxygen deficiency caused by sepsis, internal bleeding, and other serious health conditions. Oxygen levels are measured where it matters most, inside cells – not in the bloodstream like current oximeters.

COVID-19: Seeing a New Solution to Future Patient Care

The Opticyte Cell O₂ Monitor offers a new potential sightline into care for COVID-19 patients. Published case studies tracking patients with severe COVID-19 reported septic shock severe enough to require drugs to support the heart and circulation in almost 70% of patients. Utilizing the Opticyte Cell O₂ Monitor offers the potential for clinicians and researchers to access real-time, definitive data to optimize patient care decisions in the future.

Join the Opticyte Solution

Learn How